Free Trial

Lipocine (LPCN) Institutional Ownership

Lipocine logo
$2.33 +0.01 (+0.43%)
Closing price 05/14/2026 04:00 PM Eastern
Extended Trading
$2.32 -0.02 (-0.64%)
As of 08:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Lipocine (NASDAQ:LPCN)

Current
Institutional Ownership
Percentage
9.11%
Number of
Institutional Buyers
(last 12 months)
11
Total
Institutional Inflows
(last 12 months)
$10.76M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$33.41K
Get LPCN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lipocine stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

LPCN Institutional Buying and Selling by Quarter

Lipocine Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/7/2026 Dimensional Fund Advisors LP19,122$153K0.0%+57.5%0.238%
4/30/2026 AIGH Capital Management LLC200,000$1.60M0.2%N/A2.491%
2/18/2026Ikarian Capital LLC199,542$1.60M0.1%N/A3.595%
2/18/2026Squadron Capital Management LLC530,000$4.26M1.8%N/A9.550%
2/18/2026Boothbay Fund Management LLC54,893$441K0.0%N/A0.989%
2/17/2026Diadema Partners LP260,939$2.10M0.4%N/A4.702%
2/17/2026 Persistent Asset Partners Ltd70,576$567K0.3%N/A1.272%
2/12/2026 Jane Street Group LLC10,574$85K0.0%N/A0.191%
2/12/2026Renaissance Technologies LLC37,397$300K0.0%+3.6%0.674%
2/9/2026Geode Capital Management LLC62,450$502K0.0%+2.2%1.125%
11/17/2025Citadel Advisors LLC14,247$41K0.0%N/A0.257%
11/12/2025 Dimensional Fund Advisors LP12,140$35K0.0%-49.1%0.219%
2/13/2025Renaissance Technologies LLC36,032$176K0.0%-10.7%0.673%
2/12/2025Geode Capital Management LLC57,464$280K0.0%+6.0%1.074%
8/9/2024Renaissance Technologies LLC25,697$212K0.0%+21.8%0.480%
8/9/2024Dimensional Fund Advisors LP11,870$98K0.0%N/A0.222%
1/29/2024Wealth Effects LLC14,639$41K0.0%-22.0%0.275%
10/16/2023Wealth Effects LLC18,761$56K0.0%-35.9%0.353%
7/18/2023Wealth Effects LLC29,273$148K0.1%-96.1%0.563%
6/5/2023EP Wealth Advisors LLC66,983$13.40M0.2%N/A1.288%
5/4/2023Wealth Effects LLC756,674$241K0.1%-35.8%0.855%
2/13/2023Wealthspan Partners LLC73,950$29K0.0%N/A0.084%
2/2/2023Wealth Effects LLC1,178,834$469K0.3%-3.0%1.332%
2/2/2023Bailard Inc.82,957$32K0.0%N/A0.094%
11/7/2022Virtu Financial LLC93,411$42K0.0%N/A0.106%
8/3/2022Carson Advisory Inc.52,000$42K0.0%N/A0.059%
7/27/2022Bailard Inc.74,400$60K0.0%N/A0.084%
7/22/2022Aaron Wealth Advisors LLC145,045$116K0.0%+23.4%0.164%
5/13/2022EAM Investors LLC657,804$901K0.2%N/A0.743%
5/10/2022Aaron Wealth Advisors LLC117,552$85.81M1.2%N/A0.133%
4/26/2022Kestra Advisory Services LLC307,300$421K0.0%+27.9%0.347%
2/14/2022GSA Capital Partners LLP440,432$437K0.1%+39.7%0.499%


LPCN Institutional Ownership - Frequently Asked Questions

During the previous two years, 11 institutional investors and hedge funds held shares of Lipocine. The most heavily invested institutionals were Squadron Capital Management LLC ($4.26M), Diadema Partners LP ($2.10M), Ikarian Capital LLC ($1.60M), AIGH Capital Management LLC ($1.60M), Persistent Asset Partners Ltd ($567K), Geode Capital Management LLC ($502K), and Boothbay Fund Management LLC ($441K).Learn more on Lipocine's institutional investors.

9.11% of Lipocine's stock is owned by institutional investors. Learn more on LPCN's institutional investor holdings.

Of the 11 institutional investors that purchased Lipocine's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Squadron Capital Management LLC ($530K), Diadema Partners LP ($260.94K), AIGH Capital Management LLC ($200K), Ikarian Capital LLC ($199.54K), Persistent Asset Partners Ltd ($70.58K), Boothbay Fund Management LLC ($54.89K), and Dimensional Fund Advisors LP ($18.85K).

Institutional investors have bought a total of 1,350,427 shares in the last 24 months. This purchase volume represents approximately $10.76M in transactions.

The following institutional investors have sold Lipocine stock in the last 24 months: Dimensional Fund Advisors LP ($11.72K).

Institutional investors have sold a total of 11,722 shares in the last 24 months. This volume of shares sold represents approximately $33.41K in transactions.



This page (NASDAQ:LPCN) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners